Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001415889-24-020785

EVP, GLOBAL SALES sold 33,333 shares at an average $4.44 ($148,135)

  • EVP, GLOBAL SALES acquired 33,333 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ross Thomas M. EVP, GLOBAL SALES 2024-08-01 Option exercise 10b5-1 +15,476 $1.64 $25,396 40,476 D
Ross Thomas M. EVP, GLOBAL SALES 2024-08-01 Sale 10b5-1 −15,476 $4.54 $70,261 25,000 D
Ross Thomas M. EVP, GLOBAL SALES 2024-08-02 Option exercise 10b5-1 +17,857 $1.64 $29,303 42,857 D
Ross Thomas M. EVP, GLOBAL SALES 2024-08-02 Sale 10b5-1 −17,857 $4.36 $77,874 25,000 D
Derivatives
Ross Thomas M. EVP, GLOBAL SALES 2024-08-01 Option exercise · Employee Stock Option (right to buy) 10b5-1 −15,476 17,858 D
Ross Thomas M. EVP, GLOBAL SALES 2024-08-02 Option exercise · Employee Stock Option (right to buy) 10b5-1 −17,857 1 D
Open-market sales · 33,333 sh · avg $4.44 · $148,135
Loading xslF345X05/form4-08052024_100803.xml…